Sensodyne® and Discovery Network Collaborate to Explore the World of Science in Oral Health

Sensodyne® and Discovery Network Collaborate to

Explore the World of Science in Oral Health

 

Unique digital content partnership takes viewers back in time, addresses current oral health challenges and examines the role of technology in giving mouths a brighter future

 

Gurgaon, September 30: Sensodyne® has partnered with Discovery Network to launch Future Now, a five-part, global digital content series, exploring how leading future technology is helping us improve our lives, and applies in the field of oral health. The series launched on 22nd September 2015, on Discovery Network’s News Channel (D News).

 

Whether it’s how we repair the human body, using microscopic technology to improve our understanding, or exploring the causes of pain, the Future Now series with Discovery Network & Sensodyne takes us back in time, considers current challenges and looks at how technology could offer us a brighter future.

 

“Sensodyne has been dedicated to helping people relieve the sensation of sensitive teeth for over 50 years with its range of science based products,” says Dr Teresa Layer, VP Oral Health Research & Development GSK.

 

“I feel privileged to be able to immerse myself in the world of science every day of the week. This partnership with Discovery Network gave us the perfect opportunity to give our customers an insider view of the world we work in and just how it applies in the field of oral health. Here at GSK, science remains at the heart of everything we do, and as a leader in oral health science, we are dedicated to understanding key Oral Health conditions and how we can continually develop new, improved solutions and technologies to help our consumers relieve the sensation of sensitivity and improve the quality of their lives.”

 

All episodes will be available for viewing from 22nd September 2015 on http://news.discovery.com/futurenow until December 2015.

 

About GlaxoSmithKline Consumer Healthcare Ltd

GSK Consumer Healthcare Ltd is the category leader in Indian health food drinks industry. Our flagship product Horlicks leads the market, while Boost is among the top three health food drink brands that India prefers. Our manufacturing plants are located in Nabha, Rajahmundry and Sonepat. In India we have an engaged workforce of over 3500 employees. GSK also markets and distributes a range of everyday health products such as Eno, Crocin, Iodex and Sensodyne. Our marketing and distribution network comprises over 700 distributors and a direct coverage of over 8 lakh retail outlets.

 

GSK Consumer Healthcare Ltd is an associate of GlaxoSmithKline plc.of U.K, one of world’s largest consumer healthcare companies. We have a heritage that goes back over 160 years. Our purpose is to help more people around the world to do more, feel better and live longer with everyday healthcare products.  Our goal is to build a global, growing business - we call a Fast Moving Consumer Healthcare (FMCH) company - dedicated to everyday healthcare with all of the scientific expertise and quality guarantees that demands, working at the speed and with the genuine consumer understanding the modern world expects.

 

GSK Consumer Healthcare globally owns some of the world’s best loved healthcare brands, successful in over 100 countries. These include Sensodyne, Voltaren, Theraflu, Paradontax,  Panadol, Polident, Otrivin, Horlicks and Physiogel.

 

 

 

Media Contacts

 

Genesis Burson-Marsteller                                                                   GlaxoSmithKline Consumer Healthcare

 

Kuheli Ray: kuheli.ray@bm.com / +91 9999783541                                  Deepa Dey: deepa.d.dey@gsk.com